MRK vs GILD
By Alex · Tickerpine
Merck & Co., Inc. vs Gilead Sciences, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | GILD |
|---|---|---|
| Price | $145.27 | $156.04 |
| Market cap | $358.41B | $193.48B |
| P/E ratio | 117.2 | — |
| ROE | 6.96% | -20.68% |
| Profit margin | 4.77% | -10.64% |
| Revenue growth | 5.10% | 10.20% |
| Dividend yield | 2.34% | 2.10% |
| Beta | 0.22 | 0.33 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs GILD in plain English
- MRK is the bigger company — about 1.9× the market cap of GILD.
- MRK earns a higher return on equity (7% vs -21%).
- GILD is growing revenue faster (10% vs 5%).
- MRK has the higher dividend yield (2.34% vs 2.10%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
GILD return calculator
See what $1,000 in Gilead Sciences, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.